NewInsight: The AI sell-off compared to well-known stock market crashes

Elevance Health ELV

Elevance Health is the 130th largest S&P 500 company by market cap, worth $92.0 billion. Its board has 12 directors, 10 of them independent. 8 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 10.4% of the company.

CEO
Gail Boudreaux
Chair
Ramiro G. Peru
Sector
Health CareManaged Health Care
Headquarters
Indianapolis, Indiana
Founded
1946
Market cap
$92.0B
130th largest, 6 Nov 2026 close
Revenue
$199B
Fiscal year 2025
Price to sales
0.5
Market cap over revenue
Employees
97,100
10-K, 31 Dec 2025
Per employee
$947K
Market cap over employees
Connections
6
Companies sharing people

Financials

Latest quarter

Q3 2026 figures from Elevance Health's earnings release.

Filed 21 Oct 2026

Revenue
$51.4B
Up 1.4% year over year
Net income
$1.3B
Up 13% year over year
Diluted EPS
$6.27
Up 18% year over year

Reported figures

Figures from the release, against the same period a year earlier.

FigureValueYear earlierChange
Operating Revenue$50.4B$50.1B+0.7%
Diluted EPS$6.27$5.32+18%
Adjusted diluted EPS$6.99$6.03+16%
Operating Gain$1.3B$1.3B0.0%
Adjusted Operating Gain$1.3B$1.3B0.0%
Operating Margin2.5%2.6%-0.1 pts
Adjusted Operating Margin2.7%2.7%0.0 pts
Benefit expense ratio90.6%91.3%-0.7 pts
Operating expense ratio11.4%10.5%+0.9 pts
Adjusted operating expense ratio11.3%10.4%+0.9 pts
Total operating revenue$50.4B$50.1B+0.7%
Premiums$41.7B$41.8B-0.2%
Product revenue$6.5B$6.2B+4.8%
Service fees$2.3B$2.1B+6.8%
Net investment income$1.0B$625M+66%
Total revenues$51.4B$50.7B+1.4%
Benefit expense$37.8B$38.1B-0.9%
Cost of products sold$5.6B$5.4B+4.8%
Operating expense$5.8B$5.3B+9.1%
Net income$1.3B$1.2B+13%
Shareholders' net income$1.4B$1.2B+15%
Income before income tax expense$1.8B$1.4B+28%
Income tax expense$451M$219M+106%
Shareholders' earnings per diluted share$6.27$5.32+18%

Financial history

Twelve months to 30 Sep 2026, from Elevance Health's quarterly filings.

Quarters since Dec 2021

Revenue
$202B
Up 3.6% on the year before
Net income
$5.1B
2.5% of revenue
Free cash flow
$6.5B
Operating cash flow less capital spending
P/E
17.9
Market cap over net income

Quarterly results

Each quarter's revenue, net income and free cash flow.

Dec 2021 to Sep 2026

$0$20B$40B$60B202120222023202420252026$51.4B

Per employee

Twelve months to 30 Sep 2026, over 97,100 employees in Elevance Health's latest 10-K.

Revenue
$2.1M
Operating profit
$56K
2.7% of revenue
Net income
$53K
2.5% of revenue

Elevance Health's market cap since December 2008

Weekly, up to 6 Nov 2026

Show equal percentage changes as equal steps.
201020122014201620182020202220242026$92.0B

Board and leadership

Board and officers

6 people here also hold roles at other S&P 500 companies.

Board from the proxy filed 27 Mar 2026; officers filed up to 30 Sep 2026

NameTitleSinceIndependentCommitteesAge
Directors (12)
Ramiro G. PeruChairIndependent · since 2004 · Compensation and Talent, GovernanceFormer Executive Vice President and CFO, Phelps Dodge CorporationOther boards: SM EnergyChair2004YesCompensation and Talent, Governance70
Gail BoudreauxPresident and CEONot independent · since 2017Also at TargetPresident and CEO2017No65
Steven H. CollisDirectorIndependent · since 2025 · Audit, FinanceFormer Executive Chairman, Cencora, Inc.Other boards: Bausch & LombDirector2025YesAudit, Finance64
Susan D. DeVoreDirectorIndependent · since 2021 · Compensation and Talent, Finance (chair)Former CEO, Premier, Inc.Also at SolventumOther boards: Unum GroupDirector2021YesCompensation and Talent, Finance (chair)67
Robert L. Dixon Jr.DirectorIndependent · since 2011 · Compensation and Talent, FinanceOwner, RD Factor, Inc.Other boards: OktaDirector2011YesCompensation and Talent, Finance70
Lewis Hay IIIDirectorIndependent · since 2013 · Audit, FinanceOperating Advisor, Clayton, Dubilier & Rice, LLCAlso at L3HarrisDirector2013YesAudit, Finance70
Bahija JallalDirectorIndependent · since 2018 · Compensation and Talent, Governance (chair)CEO, Immunocore Holdings plcOther boards: Immunocore HoldingsDirector2018YesCompensation and Talent, Governance (chair)64
Antonio F. NeriDirectorIndependent · since 2017 · Compensation and Talent (chair), GovernancePresident and CEO, Hewlett Packard Enterprise CompanyAlso at Hewlett Packard EnterpriseDirector2017YesCompensation and Talent (chair), Governance58
Ryan M. SchneiderDirectorIndependent · since 2019 · Audit (chair), GovernanceFormer CEO and President, Anywhere Real Estate Inc.Director2019YesAudit (chair), Governance56
Amy W. SchulmanDirectorIndependent · since 2026 · Audit, FinanceManaging Partner, Polaris PartnersOther boards: Alnylam PharmaceuticalsDirector2026YesAudit, Finance65
Deanna D. StrableDirectorIndependent · since 2022 · Audit, GovernanceChairman of the Board, President and CEO, Principal Financial Group, Inc.Other boards: Principal FinancialDirector2022YesAudit, Governance57
Deanna D. Strable-SoethoutDirectorAlso at Principal Financial GroupDirector
Officers (8)
Mark KayeEVP & CFOLast filed 4 Mar 2026EVP & CFO
Ryan R. CraigEVP & Chief HR OfficerLast filed 4 Sep 2026EVP & Chief HR Officer
Peter D. HaytaianEVP & Pres Carelon & CarelonRxLast filed 4 Mar 2026EVP & Pres Carelon & CarelonRx
Charles Morgan Kendrick Jr.EVP & President, CommercialLast filed 9 Mar 2026EVP & President, Commercial
Ratnakar LavuEVP & Chief Digital Info OfrLast filed 4 Mar 2026EVP & Chief Digital Info Ofr
Felicia F. NorwoodEVP &Chief Health Benefits OfrAlso at Wells FargoLast filed 4 Mar 2026EVP &Chief Health Benefits Ofr
Ronald W. PenczekCAO & ControllerLast filed 15 Jun 2026CAO & Controller
Erin M. WesslingEVP & Chief Legal OfficerLast filed 4 Sep 2026EVP & Chief Legal Officer

Companies that share people with Elevance Health

Each person's title here, then at the other company.

  • Hewlett Packard Enterprise HPE
    • Antonio F. Neri: Director here, President and CEO there
  • L3Harris LHX
    • Lewis Hay III: Director here, Lead Independent Director there
  • Principal Financial Group PFG
    • Deanna D. Strable-Soethout: Director here, Chair, President and CEO there
  • Solventum SOLV
    • Susan D. DeVore: Director here, Director there
  • Target TGT
    • Gail Boudreaux: President and CEO here, Director there
  • Wells Fargo WFC
    • Felicia F. Norwood: EVP &Chief Health Benefits Ofr here, Director there

Owners and trading

Largest institutional holders

Each fund group's share of Elevance Health. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 30.8% of Elevance Health.

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 6 Nov 2025 to 6 Nov 2026

Directors and officers sold $7.0 million of stock in 7 sales and bought $2.2 million in 3 purchases in the 12 months to 6 Nov 2026.

DatePersonTitleTypeSharesValue
5 Nov 2026SaleRatnakar LavuEVP & Chief Digital Info OfrEVP & Chief Digital Info OfrSale1,300$572K
22 Oct 2026SaleMark KayeEVP & CFOEVP & CFOSale10,584$4.7M
17 Jul 2026BuyGail BoudreauxPresident and CEOPresident and CEOBuy2,725$1.0M
17 Jul 2026BuyRamiro G. PeruChairChairBuy1,000$366K
12 Jun 2026SaleRonald W. PenczekCAO & ControllerCAO & ControllerSale369$149K
11 Jun 2026SaleRobert L. Dixon Jr.DirectorDirectorSale151$61K
19 May 2026SaleRonald W. PenczekCAO & ControllerCAO & ControllerSale1,531$617K
12 Mar 2026SaleAmy W. SchulmanDirectorDirectorSale26$7K
6 Mar 2026SaleCharles Morgan Kendrick Jr.EVP & President, CommercialEVP & President, CommercialSale3,196$911K
5 Mar 2026BuySteven H. CollisDirectorDirectorBuy3,000$870K

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 27 Oct 2023 to 27 Oct 2026

16 people disclosed 32 purchases and 23 sales of Elevance Health stock since October 2023.

DateMember or officialTypeAmount
20 Jul 2026Rohit Khanna (House, D-CA)House, D-CA · SoldSale$1,001 to $15,000$1K to $15K
18 May 2026Markwayne Mullin (Secretary)Secretary · SoldSale$50,001 to $100,000$50K to $100K
27 Apr 2026Donald J Trump (President)President · BoughtPurchase$15,001 to $50,000$15K to $50K
27 Apr 2026Donald J Trump (President)President · BoughtPurchase$1,001 to $15,000$1K to $15K
13 Apr 2026Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K
10 Apr 2026Donald J Trump (President)President · BoughtPurchase$50,001 to $100,000$50K to $100K
27 Mar 2026Alan Armstrong (Senate, R-OK)Senate, R-OK · BoughtPurchase$1,001 to $15,000$1K to $15K
18 Mar 2026Donald J Trump (President)President · SoldSale$15,001 to $50,000$15K to $50K
17 Mar 2026Donald J Trump (President)President · SoldSale$250,001 to $500,000$250K to $500K
24 Feb 2026Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$15,001 to $50,000$15K to $50K

Showing 10 of 55 trades

Workforce and hiring

Workforce

Headcount at 31 Dec 2025

Employees
97,100

Employees, last 10 fiscal years

Up 16% in five years, from 83,400 in 2020 to 97,100 in 2025.

As of December 31, 2025, our employee population, including all full-time, part-time and temporary workers, consisted of approximately 97,100 individuals, 71,900 in the United States and 25,200 internationally.
Elevance Health Form 10-K

Open roles

Jobs listed on Elevance Health's careers site, each counted once.

Daily, up to 3 Nov 2026

Open roles
257
On 3 Nov 2026
Change
-8
Down 3.0% since 27 Oct 2026
Top function
Customer & Retail
54% of open roles
Remote
22%
Fully remote roles

Open roles in detail

27 Oct 2026 to 3 Nov 2026

27 Oct3 Nov257

WARN layoff notices

Notices filed under Elevance Health's own name or a subsidiary's listed in its 10-K.

Notices from 7 Nov 2023 to 7 Nov 2026

Elevance Health filed 4 notices covering 424 workers since November 2023.

NoticePlaceWorkersEffective
15 Sep 2026Metairie, LA216-
27 Jul 2026DC852 Oct 2026
15 Oct 2024Cerritos, CA6418 Oct 2024
15 Oct 2024Woodland Hills, CA5918 Oct 2024

Timeline

Leadership changes, layoffs and insider sales

7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025

1 departure and 3 appointments of directors and officers, WARN layoff notices on 2 days and 1 large insider sale in the last two years.

Left the company or board 1Appointed 3WARN layoff notices 2Large insider sales 1Jan 2025AprJulOctJan 2026AprJulOct

Insider sales of $1 million or more, and the largest tenth of Elevance Health's insider sales.

Events, newest first